Pennsylvania treasurer leads calls to lower price of remdesivir
Remdesivir, originally intended as a treatment for Ebola, was developed with $70 million in taxpayer funds.
Remdesivir, originally intended as a treatment for Ebola, was developed with $70 million in taxpayer funds.
UPMC’s pledge to spend $1 billion on life science innovations over four years is expected to support early stage development of medical devices, software, drugs and more nationwide.
A Chinese scientist accused of participating in a conspiracy to steal trade secrets from pharmaceutical giant GlaxoSmithKline is back in the United States after being extradited to stand trial in Philadelphia.